Cabometyx® is the first and only systemic therapy to be approved in the European Union for previously treated unresectable or metastatic neuroendocrine tumors, regardless of tumor site, grade or ...

Konstanz researchers identify an enzyme that plays a role in the migration of cells in our body—not only during normal tissue ...

A retrospective analysis found whole brain radiation therapy alongside immune checkpoint inhibitors led to “brilliant” 2-year ...

Stereotactic body radiotherapy costs less and has shown better safety compared with immunotherapy and tyrosine kinase ...

Certain respiratory infections could trigger a reawakening of dormant cancer cells in the body, according to a new study.

Patritumab deruxtecan shows promising survival rates and manageable safety in treating leptomeningeal metastatic disease, ...

Researchers who conducted a real-world analysis of trastuzumab deruxtecan found the drug to be effective in treating metastatic breast cancer, though survival outcomes did not reach clinical trial ...

This new article publication from Acta Pharmaceutica Sinica B, discusses how a photodynamic nanohybrid system reverses hypoxia and augments anti-primary and metastatic tumor efficacy of immunotherapy.

Metastatic cancer is an advanced stage where cancer cells spread beyond the original site. It’s harder to treat, often resisting chemotherapy and requiring more targeted, ongoing treatment approaches.

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription.